Dendreon · 3 days ago
Sr. Director, Business Development and Corporate Strategy
Seal Beach, CA
Full-time
Onsite
Director/Executive
10+ years expDendreon is transforming the battle against cancer with personalized immunotherapy. The Senior Director of Business Development & Corporate Strategy will drive growth through strategic partnerships, licensing, and corporate development initiatives, requiring an experienced leader in the biotech or pharmaceutical industry.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Serve as a key corporate strategist identifying high-impact opportunities for external innovation and investment
Identify, evaluate, and lead strategic transactions and investments aligned with Dendreon’s business strategy, including first-in-class and differentiated therapeutic modalities (e.g., ADCs or other complex platforms)
Lead the search, evaluation, and acquisition of innovative clinical- to commercial-stage therapeutic assets, with emphasis on late-stage (Phase II/III), first-in-class programs aligned with Dendreon’s core therapeutic areas, including immunotherapy, urology, and oncology
Evaluate complex therapeutic modalities, including antibody-drug conjugates (ADCs) or similarly advanced platforms, assessing scientific differentiation, clinical risk, and commercial potential
Conduct robust diligence with cross-functional support from Clinical, Regulatory, CMC, IP, Commercial, and Finance to drive informed decisions and maximize asset value
Develop detailed market assessments, forecasts, valuation models, and scenario analyses for internal and external opportunities
Partner closely with internal teams (R&D, Clinical, Regulatory, Commercial, Finance, Legal/IP) to perform scientific and commercial diligence, valuation modeling, and competitive landscape analyses
Build and execute a business development plan to position Dendreon’s manufacturing capabilities as a CDMO partner for emerging and established biotech clients
Identify and engage prospective CDMO partners, from early-stage startups to mid-size biotechs, structuring proposals and partnerships that leverage Dendreon’s technical and operational strengths
Collaborate with Technical Operations, Quality, and Regulatory to ensure operational readiness and partner alignment on timelines and technical feasibility
Represent Dendreon at relevant CDMO and manufacturing conferences and in client-facing discussions
Lead the structuring, negotiation, and execution of term sheets and definitive agreements for BD and CDMO transactions
Manage internal due diligence processes, coordinate with legal on contract development, and align stakeholders on deal terms and governance
Partner with the CEO and Senior Leadership Team to refine corporate strategy and long-range planning
Prepare and present executive summaries, board materials, and strategic recommendations based on external opportunity assessments
Qualification
Required
10+ years of progressive experience in business development in the biotech or pharmaceutical industry
Demonstrated ability to lead BD, M&A, licensing, or investment transactions from sourcing through execution
Advanced degree required: MBA, PhD, MD, or equivalent scientific or financial training
Strong understanding of complex therapeutic modalities, such as ADCs, biologics, cell therapies, or other advanced platforms
Deep financial acumen including valuation modeling, risk/return analysis, and deal structuring
Executive presence and excellent communication skills with ability to build trust internally and externally
Strong cross-functional leadership with proven ability to influence stakeholders across Clinical, Technical Ops, Regulatory, and Legal
Deal Sheet Required
Willingness to travel up to 50%+, including international travel
Preferred
Board-level exposure or experience presenting to board/investment committees
Direct experience supporting or leading CDMO strategy or partnerships
Strong network within the VC/PE community focused on early- to mid-stage biotech
Familiarity with oncology, immunotherapy, urology, or cellular immunotherapies. Prior operating experience within a biotech or biopharma company
Consulting or operating experience in high-growth biotech or commercial-stage biopharma environments
Global experience with international partnerships, particularly the biotech or pharmaceutical environments in China
Experience in venture capital, private equity, or investment banking within the life sciences industry
Company
Dendreon
Dendreon was a biotechnology company produces immunotherapy for prostate cancer.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
unknown2017-06-29Acquired
2000-06-23IPO
Leadership Team
Bev Eckert
Sr. Assistant to the VP& CIO
Jonathan Wells, SHRM-SCP, SPHR
Human Resources Business Partner
Recent News
MarketsandMarkets Research Pvt. Ltd.
2025-08-13
Company data provided by crunchbase